5 min read
0
The Ultimate Guide of BUSINESS
Medtronic particularly points to a “novel and proprietary approach” that addresses insulin degradation, preservative loss, and occlusions — all issues that may find yourself in disrupted insulin supply and due to this fact larger blood sugars. Of course, Medtronic did get FDA clearance in July 2021 for its new extended-wear infusion set, designed to last greater than twice so lengthy as existing infusion sets that connect traditional tubed pumps to the body for insulin supply. That means it could be worn on the body for up to 7 days — in comparability with existing units that have to be modified…